AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| OLV | Ann: Appendix 4C - March 2018 quarter | 23/04/18 | 3 | 320 | |||
|
|||||||
| OLV | ESOP - getting set prior to the re-rate | 17/04/18 | 5 | 475 | |||
|
|||||||
| OLV | Ann: Appendix 3B | 16/04/18 | 0 | 89 | |||
|
|||||||
| OLV | Tabcorp UK Sun Bets | 12/04/18 | 24 | 2.6K | |||
|
|||||||
| OLV | Ann: Chairman's Address to AGM | 09/03/18 | 15 | 2.6K | |||
|
|||||||
| OLV | Ann: OLV expands Customer Partnership into Multi-Year Agreement | 27/02/18 | 9 | 1.2K | |||
|
|||||||
| OLV | Ann: OtherLevels Multi-Year Agreement Clarification | 27/02/18 | 2 | 291 | |||
|
|||||||
See All Discussions
ASX News